92 related articles for article (PubMed ID: 2984793)
21. Prevalence of antibodies to human T-cell leukemia virus.
Opperman JC; Rubin DM; Glocer J; Swanevelder C; Odendaal M; Prozesky OW
S Afr Med J; 1984 Jul; 66(3):86. PubMed ID: 6330916
[No Abstract] [Full Text] [Related]
22. Antibody cross-reactivity of alphaherpesviruses as mirrored in naturally infected primates.
Katz D; Shi W; Krug PW; Henkel R; McClure H; Hilliard JK
Arch Virol; 2002 May; 147(5):929-41. PubMed ID: 12021865
[TBL] [Abstract][Full Text] [Related]
23. Comparative seroepidemiology of HTLV-I and HTLV-III in the French West Indies and some African countries.
de-Thé G; Gessain A; Gazzolo L; Robert-Guroff M; Najberg G; Calender A; Peti M; Brubaker G; Bensliman A; Fabry F
Cancer Res; 1985 Sep; 45(9 Suppl):4633s-4636s. PubMed ID: 2990698
[TBL] [Abstract][Full Text] [Related]
24. Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in Israel.
Ben-Ishai Z; Haas M; Triglia D; Lee V; Nahmias J; Bar-Shany S; Jensen FC
Nature; 1985 Jun 20-26; 315(6021):665-6. PubMed ID: 2989699
[TBL] [Abstract][Full Text] [Related]
25. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
26. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
[TBL] [Abstract][Full Text] [Related]
27. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa.
Biggar RJ; Johnson BK; Oster C; Sarin PS; Ocheng D; Tukei P; Nsanze H; Alexander S; Bodner AJ; Siongok TA
Int J Cancer; 1985 Jun; 35(6):763-7. PubMed ID: 2989191
[TBL] [Abstract][Full Text] [Related]
28. Comparison of assays for antibody to HTLVI.
White PM
J Clin Pathol; 1988 Jun; 41(6):700-2. PubMed ID: 2838531
[TBL] [Abstract][Full Text] [Related]
29. Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.
Kobayashi S; Yoshida T; Hiroshige Y; Matsui T; Yamamoto N
J Clin Microbiol; 1988 Feb; 26(2):308-12. PubMed ID: 2893807
[TBL] [Abstract][Full Text] [Related]
30. Neutralizing antibodies to simian papovavirus SA12 in Old World primates in laboratory colonies: high prevalence in baboons.
Braun L; Kalter SS; Yakovleva LA; Kaschula VR; Shah KV
J Med Primatol; 1980; 9(4):240-6. PubMed ID: 6252324
[TBL] [Abstract][Full Text] [Related]
31. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy].
Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP
Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies reactive with human T cell lymphotropic virusI (HTLVI) p19 internal core protein: cross-reactivity with normal tissues and differential reactivity with HTLV types I and II.
Palker TJ; Scearce RM; Ho W; Copeland TD; Oroszlan S; Popovic M; Haynes BF
J Immunol; 1985 Jul; 135(1):247-54. PubMed ID: 2987346
[TBL] [Abstract][Full Text] [Related]
33. HTLV-III: the etiologic agent of AIDS.
Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
[TBL] [Abstract][Full Text] [Related]
34. HTLV and immunosuppression.
Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
[TBL] [Abstract][Full Text] [Related]
35. HTLV-I infection in the Free State region of South Africa: a sero-epidemiologic study.
van der Ryst E; Joubert G; Smith MS; Terblanche M; Mollentze F; Pretorius AM
Cent Afr J Med; 1996 Mar; 42(3):65-8. PubMed ID: 8653770
[TBL] [Abstract][Full Text] [Related]
36. Antigenicity of human T-cell leukemia virus-associated gp52: greater response in leukemia patients compared to healthy donors exposed to the virus.
Robert-Guroff M; Clark JW
Cancer Res; 1985 Jul; 45(7):3374-7. PubMed ID: 2988770
[TBL] [Abstract][Full Text] [Related]
37. HTLV-I-reactive antibody in the northern and eastern Transvaal.
Botha MC; Jones M; de Klerk WA; Yamamoto N; Kobayashi S
S Afr Med J; 1985 May; 67(18):707. PubMed ID: 2986301
[No Abstract] [Full Text] [Related]
38. Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors.
Blomberg J; Fäldt R
Br J Haematol; 1985 Jul; 60(3):555-7. PubMed ID: 2990523
[TBL] [Abstract][Full Text] [Related]
39. Lack of HTLV-I antibodies in Africans.
Weiss RA; Cheingsong-Popov R; Clayden S; Pegram S; Tedder RS; Barzilai A; Rubenstein E
Nature; 1986 Feb 27-Mar 5; 319(6056):794-5. PubMed ID: 3005874
[No Abstract] [Full Text] [Related]
40. Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies.
Tóth FD; Szabó B; Váczi L; Kiss A; Kovács I; Rák K; Kiss C; Gallo RC
Acta Microbiol Hung; 1984; 31(4):387-92. PubMed ID: 6100223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
